Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Shares Outstanding (2020 - 2025)

IceCure Medical (ICCM) has disclosed Shares Outstanding for 6 consecutive years, with $73.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 29.26% to $73.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $73.1 million through Dec 2025, up 29.26% year-over-year, with the annual reading at $73.1 million for FY2025, 29.26% up from the prior year.
  • Shares Outstanding for Q4 2025 was $73.1 million at IceCure Medical, up from $56.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $73.1 million in Q4 2025, with the low at $1.0 million in Q4 2021.
  • Average Shares Outstanding over 5 years is $44.4 million, with a median of $45.7 million recorded in 2023.
  • The sharpest move saw Shares Outstanding surged 19128.34% in 2021, then rose 0.23% in 2023.
  • Over 5 years, Shares Outstanding stood at $1.0 million in 2021, then skyrocketed by 4312.32% to $45.6 million in 2022, then grew by 0.23% to $45.7 million in 2023, then increased by 23.7% to $56.6 million in 2024, then increased by 29.26% to $73.1 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $73.1 million, $56.6 million, and $45.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.